NCT01014897.

Trial name or title	tDCS in chronic stroke recovery—pilot
Methods	Double‐blind randomised sham‐controlled cross‐over trial
Participants	45 people between 18 and 80 years of age with single symptomatic stroke more than 3 months ago with hand/arm weakness and ability to perform required tests and provide consent; Modified Ashworth scale < 3; ROM functional at shoulder, elbow, wrist and hand Exclusion criteria: more than 1 symptomatic stroke in MCA territory or bilateral involvement; severe medical or psychiatric conditions, drug abuse, seizure disorder; pregnancy/breast‐feeding; SAH, lobar haemorrhage; people who cannot have tDCS (prior head surgery, pacemakers, metallic implants in the head, etc); people taking antiadrenergic medications
Interventions	Experimental: subcortical: subcortical stroke participants will receive tDCS stimulation and sham in random order; tDCS and sham will be applied in random order during standardised occupational therapy Experimental: cortical: participants will receive active and sham tDCS in random order; tDCS and sham will be applied in random order during standardised occupational therapy
Outcomes	Primary outcome measures: WMFT at baseline and after the end of the intervention period; UE‐FM at baseline and after the end of the intervention period Secondary outcome measures: adverse events during the intervention period
Starting date	April 2009
Contact information	Timea Hodics, MD Timea.Hodics@UTSouthwestern.edu
Notes